Search results
Epstein-Barr may play a role in some long COVID; coronavirus can impair blood sugar processing by...
Reuters via Yahoo News· 2 years agoMore than 90% of adults have been infected with Epstein-Barr virus (EBV). Among 280 patients with...
Inside long COVID’s war on the body: Researchers are trying to find out whether the virus has the...
Fortune via Yahoo Finance· 6 months agoLong COVID is no stranger to either patients or those immersed in studies of its effects. In the...
Who’s most at risk of developing long COVID? Experts think these 6 groups of people might be
Fortune via Yahoo Finance· 2 years agoCOVID just got a lot more complicated. With cases rising in the U.S. and globally yet again, fueled...
QIAGEN (QGEN) Broadens QuantiFERON Line With EBV RUO Assay
Zacks via Yahoo Finance· 8 months agoQIAGEN (QGEN) notes that T-cells are vital in combatting viral infections and the QuantiFERON-EBV...
Moderna (MRNA) Stock Outperformed Industry YTD: Here's Why
Zacks via Yahoo Finance· 1 week agoDespite the declining top line, shares of Moderna MRNA continue to soar thanks to its encouraging...
Moderna (MRNA) Q1 Earnings Beat Estimates, Revenues Down Y/Y
Zacks via Yahoo Finance· 1 month agoModerna, Inc. MRNA reported earnings of $3.07 per share in the first quarter of 2024, beating the...
Long Covid: the cause, the consequence, the future of clinical trials
Clinical Trials Arena via Yahoo Finance· 3 weeks agoImperial College London hopes its recently published Long Covid study will lead to further clinical...
Moderna (MRNA) Posts Pipeline Progress, Secures Blackstone Funding
Zacks via Yahoo Finance· 2 months agoModerna (MRNA) posts data on three experimental vaccines and intends to advance them to late-stage...
OPKO Health, Inc. (NASDAQ:OPK) Q4 2022 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 1 year agoOPKO Health, Inc. (NASDAQ:OPK) Q4 2022 Earnings Call Transcript February 23, 2023 Operator: Good...
Is Moderna Stock Going to $214? 1 Wall Street Analyst Thinks So.
Motley Fool via Yahoo Finance· 2 months agoFor many, Moderna (NASDAQ: MRNA) stock is yesterday's news. The stock earned a great deal of...